Soft-tissue-Sarcoma
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities (Soft-tissue-Sarcoma)
Pre-treatment FDG PET/CT and T1-weighted plus fat-suppressed T2-weighted or STIR MRI of 51 patients with soft-tissue sarcoma of the extremities from McGill, with tumor contours, clinical data and lung metastasis outcome labels.
Overview
Soft-tissue-Sarcoma is a radiomics collection from McGill University, published by The Cancer Imaging Archive in 2015 together with the study by Vallières and colleagues in Physics in Medicine and Biology. It pairs pre-treatment FDG PET/CT and MRI of patients with soft-tissue sarcoma of the arms and legs with manual tumor contours and follow-up data, and was assembled to test whether texture features from fused PET and MRI predict which patients later develop lung metastases.
Composition
The Data Access table lists 51 subjects, 102 studies, 612 DICOM series and 38,283 images (9.87 GB). Every patient has one PET/CT study and one MR study. The cohort was imaged between November 2004 and November 2011, before treatment, and patients who already had metastatic or recurrent disease at presentation were excluded. Nineteen patients developed lung metastases during follow-up. In the open clinical spreadsheet, the thigh is the most frequent primary site (28 patients), the most frequent histology groups are malignant fibrous histiocytoma (17), liposarcoma (11) and leiomyosarcoma (10), and 28 tumors are high grade. It also records treatment, outcome and follow-up times.
Acquisition
All PET/CT scans come from one GE Discovery ST at the McGill University Health Centre, acquired about an hour after FDG injection. MRI was clinical routine with protocols that varied between patients: 12 exams were done at the same centre and 39 elsewhere, on GE, Philips and Siemens scanners. Each patient has an axial T1-weighted series and one fat-suppressed fluid-sensitive series, either T2-weighted fat saturated (26 patients) or STIR (25 patients). Copies of both MR series registered and resampled to the PET grid are included.
Annotations
A radiation oncologist drew 3D tumor contours slice by slice on the fat-suppressed MR series. For the 32 patients with visible edema there are two contours, one for the mass alone and one that includes the edema. The contours were transferred to the PET, CT and T1-weighted series by rigid registration and are stored as RTSTRUCT objects for every series. The binary lung metastasis label is given per patient.
Known limitations
- Small single-centre cohort with 19 positive cases for the main outcome.
- MRI protocols, planes and scanners are not uniform, and the T2-weighted and STIR series are pooled as one category.
- Dates in the images were shifted for de-identification.
- Contours on PET, CT and T1-weighted images are propagated by registration, not drawn on those images.
Cohort
Aggregate numbers from the sources below. Bars are relative to the 51 subjects.
Sex
- Female 27 53%
- Male 24 47%
Age
mean 54.8± 17 · range 16 to 83Contrast combinations
How many subjects have exactly each set of contrasts.
| T1w | T2w | STIR | Subjects with exactly this set |
|---|---|---|---|
26 | |||
25 |
Modality
subjects
- CT 51 100%
- PET 51 100%
- MRI 51 100%
Contrast / sequence
subjects, values can overlap
- T1-weighted 51 100%
- T2-weighted 26 51%
- STIR 25 49%
PET tracer
subjects
- [18F]FDG 51 100%
Condition
subjects, values can overlap
- Soft tissue sarcoma 51 100%
Scanner vendor
subjects
- GE HealthCare 51 100%
- Philips 9 18%
- Siemens Healthineers 8 16%
Country
subjects
- Canada 51 100%
License and access
Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer
Download without an account
DICOM images and RTSTRUCT contours are downloaded with the TCIA Data Retriever from a manifest file and are also available in the NCI Imaging Data Commons. The clinical spreadsheet is a direct download. No account is needed.
Creative Commons Attribution 3.0 Unported
Older version of CC BY. Use, share and adapt the data for any purpose, including commercial use, as long as you credit the creators.
The Data Access table lists CC BY 3.0 for both the images with radiation therapy structures and the clinical data. The page also requires the data citation under the TCIA Data Usage Policy.
What you can do
- Yes
- Yes
- Yes
- Yes
What you can share
- Yes
- Yes
- Yes
What you must do
- Yes
- Share alike No
- No
- No
- Manuscript review No
- Release code No
- Return results No
- Delete after use No
Limits
- No
- Location limits No
Citation
Vallières, M., Freeman, C. R., Skamene, S. R., & El Naqa, I. (2015). A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities (Soft-tissue-Sarcoma) [Dataset]. The Cancer Imaging Archive. https://doi.org/10.7937/K9/TCIA.2015.7GO2GSKS
All numbers
Every number on this page, as stored in stats.csv, with its source.
| Measure | Breakdown | Value | Source |
|---|---|---|---|
| Subjects | total | 51 | tcia-soft-tissue-sarcoma Data Access (Version 1) |
| Studies | total one PET/CT study and one MR study per patient | 102 | tcia-soft-tissue-sarcoma Data Access (Version 1) |
| Scans | total DICOM series, including RTSTRUCT and the MR series registered to PET | 612 | tcia-soft-tissue-sarcoma Data Access (Version 1) |
| Images | total DICOM images | 38,283 | tcia-soft-tissue-sarcoma Data Access (Version 1) |
| Subjects | condition=soft_tissue_sarcoma histologically proven STS of the extremities | 51 | vallieres2015 Abstract |
| Subjects | modality=CT CT of the PET/CT exam | 51 | tcia-sts-digest Patient ID, Modality columns |
| Subjects | modality=PT | 51 | tcia-sts-digest Patient ID, Modality columns |
| Subjects | modality=MR | 51 | tcia-sts-digest Patient ID, Modality columns |
| Subjects | tracer=fdg | 51 | tcia-soft-tissue-sarcoma Detailed Description |
| Scans | modality=CT | 51 | tcia-sts-digest Series Instance UID, Modality columns |
| Scans | modality=PT | 51 | tcia-sts-digest Series Instance UID, Modality columns |
| Scans | modality=MR 102 clinical MR series plus 102 copies registered and resampled to PET | 204 | tcia-sts-digest Series Instance UID, Modality columns |
| Subjects | contrast=T1w axial T1-weighted for all patients | 51 | tcia-soft-tissue-sarcoma Detailed Description |
| Subjects | contrast=T2w T2-weighted fat-saturated | 26 | tcia-soft-tissue-sarcoma Detailed Description |
| Subjects | contrast=STIR used where no T2-weighted fat-saturated series was available | 25 | tcia-soft-tissue-sarcoma Detailed Description |
| Subjects | contrast_set=T1w+T2w registered series Aligned_T1toPET and Aligned_T2FStoPET | 26 | tcia-sts-digest Patient ID, Series Description columns |
| Subjects | contrast_set=STIR+T1w registered series Aligned_T1toPET and Aligned_STIRtoPET | 25 | tcia-sts-digest Patient ID, Series Description columns |
| Subjects | vendor=ge GE Discovery ST PET/CT for all; 33 subjects also have GE MRI | 51 | tcia-sts-digest Patient ID, Manufacturer columns |
| Subjects | vendor=philips MRI | 9 | tcia-sts-digest Patient ID, Manufacturer columns |
| Subjects | vendor=siemens MRI | 8 | tcia-sts-digest Patient ID, Manufacturer columns |
| Subjects | country=CA all PET/CT scans at the McGill University Health Centre, Montreal; 39 MRI exams came from an outside institution | 51 | tcia-soft-tissue-sarcoma Detailed Description, Acknowledgements |
| Subjects | sex=female | 27 | tcia-sts-clinical Patient ID, Sex columns |
| Subjects | sex=male | 24 | tcia-sts-clinical Patient ID, Sex columns |
| Subjects | age=10-19 | 2 | tcia-sts-clinical Patient ID, Age columns |
| Subjects | age=20-29 | 5 | tcia-sts-clinical Patient ID, Age columns |
| Subjects | age=30-39 | 2 | tcia-sts-clinical Patient ID, Age columns |
| Subjects | age=40-49 | 8 | tcia-sts-clinical Patient ID, Age columns |
| Subjects | age=50-59 | 9 | tcia-sts-clinical Patient ID, Age columns |
| Subjects | age=60-69 | 15 | tcia-sts-clinical Patient ID, Age columns |
| Subjects | age=70-79 | 8 | tcia-sts-clinical Patient ID, Age columns |
| Subjects | age=80-89 | 2 | tcia-sts-clinical Patient ID, Age columns |
| Mean age | total | 54.8 | tcia-sts-clinical Age column |
| Age SD | total | 17 | tcia-sts-clinical Age column |
| Median age | total | 59 | tcia-sts-clinical Age column |
| Minimum age | total | 16 | tcia-sts-clinical Age column |
| Maximum age | total | 83 | tcia-sts-clinical Age column |
Sources
The keys used in the table above.
- tcia-soft-tissue-sarcoma TCIA Soft-tissue-Sarcoma collection page (version 1, updated 2015/06/01) website
- tcia-sts-clinical TCIA Soft-tissue-Sarcoma clinical data (INFOclinical_STS.xlsx, open download, CC BY 3.0), sheet Clinical Information, one row per patient computed
- tcia-sts-digest TCIA Soft-tissue-Sarcoma radiology metadata digest (doiJNLP-zgVcrK7I-nbia-digest.xlsx, open download, CC BY 3.0), counted per unique Patient ID computed
- vallieres2015 Vallières et al. 2015, Physics in Medicine and Biology 60(14) paper